Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2Kailin Yin, Nadia R. Roan, Michael J. Peluso et al.|Nature Immunology|2024Cited by 338
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionMichael J. Peluso, Timothy J. Henrich, John Winslow et al.|The Journal of Infectious Diseases|2021Cited by 332
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J. Peluso, Timothy J. Henrich, Amelia N. Deitchman et al.|Cell Reports|2021Cited by 266
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological ManifestationsBing Sun, Lynn Pulliam, Norina Tang et al.|Cells|2021Cited by 187
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J. Peluso, Bryan Greenhouse, Saki Takahashi et al.|Science Advances|2021Cited by 150